Related Experiment Videos
Intravenous heparin for cardiopulmonary bypass is an acute vasodilator
Michael J Jacka1, Andrew G Clark
1Department of Anesthesia and Critical Care, University of Alberta, Edmonton, Alberta, Canada.
Study Objectives:
To investigate the changes in hemodynamic profile during cardiopulmonary bypass, and determine the effect of intravenous (IV) heparin on serum chemistry and acid-base status.
Design:
Prospective study.
Setting:
Three Canadian hospitals.
Patients:
43 consecutive patients undergoing elective aortocoronary bypass.
Interventions:
Anesthetic technique was standarized. Hemodynamic profile, blood gases, and serum electrolytes were measured immediately before IV heparin for cardiopulmonary bypass, and 5 minutes after.
Results:
Mean arterial pressure (MAP) decreased by a mean of 11.2 mmHg (12.5%, p = 0.0001) in all patients, of whom 28% were treated with vasoactive drugs to restore MAP. Mean systemic vascular resistance decreased by 418 dyne sec/cm(5) (25%, p = 0.0001), and mean serum potassium increased by 0.14 meq/L (p = 0.0002). The reduction in MAP correlated strongly with the reduction in SVR (p = 0.004), but not with changes in potassium or other variables.
Implications:
Mean arterial pressure is significantly affected by IV heparin for cardiopulmonary bypass. The hemodynamic mechanism is systemic vasodilation, implying that treatment with a short-acting vasoconstrictor is appropriate, if necessary. Unlike earlier studies, the increase in serum potassium observed, although reproducible, was trivial.